Skip to main content
. 2021 Jun 9;26(9):e1609–e1618. doi: 10.1002/onco.13822

Figure 3.

Figure 3

Median PFS by RDI category. * Indicates p < .05 reported for the difference in median PFS; ** indicates .05 ≤ p < .10. Unmarked comparisons reported p > .10 or did not report p values. Abbreviations: CRC, colorectal cancer; FOLFIRI, folinic acid (leucovorin), fluorouracil (5‐FU), and irinotecan; mFOLFOX6, modified folinic acid (leucovorin), fluorouracil (5‐FU), and oxaliplatin (six cycles postoperative); PFS, progression‐free survival; RDI, relative dose intensity.